The Telomeric DNA Damage Response As a Therapeutic Target in Idiopathic Pulmonary Fibrosis

Researchers identified telomeric DNA damage signaling as a driver of idiopathic pulmonary fibrosis, with targeted inhibition reversing key molecular and fibrotic features of disease.